Key Takeaways
- Early‑onset colorectal cancer is rising; it is now the leading cause of cancer death in adults under 50.
- Both Shameka Taylor and Howard Robinson were diagnosed at age 36 despite having no family history of the disease.
- Symptoms such as changes in bowel habits, blood in stool, unexplained weight loss, and night sweats that persist >2 weeks warrant a prompt colonoscopy.
- Screening guidelines recommend a first colonoscopy at age 45, but individuals with symptoms should seek evaluation earlier.
- Late‑stage (stage 3‑4) colorectal cancer has a markedly poorer prognosis—about a 13 % five‑year survival rate versus ~60 % overall.
- Self‑advocacy and persistence in seeking second opinions can be lifesaving when initial providers dismiss concerns.
- Treatment may involve chemotherapy, multiple surgeries, and immunotherapy; ongoing therapy can extend survival but brings uncertainty with scans every few months.
- Support organizations like the Colorectal Cancer Alliance and the American Cancer Society provide resources for patients, caregivers, and those seeking screening information.
Shameka Taylor, a 39‑year‑old Kalamazoo resident, never imagined cancer would become part of her story. “As a young person you don’t ever think cancer is going to be part of your story,” she said, recalling the shock of her Stage 4 colorectal cancer diagnosis. At 36, in August 2022, she was first told she had Stage 3 disease. Initially angry and questioning “Why me?” she later reframed the thought to “Why not me?” and began to confront the reality of her condition. Taylor attributed early symptoms—fatigue and anxiety—to the demands of raising two sons, never suspecting cancer. When flu‑like episodes recurred every few weeks, she searched online; colon cancer appeared in the results, but she dismissed it because the information emphasized older adults.
The cancer had already metastasized to her pancreas, bile duct, liver, and part of her stomach. To date she has undergone chemotherapy, four surgeries, and is now receiving immunotherapy slated to continue until September 2026. Surgeons removed portions of her pancreas, bile duct, colon, and stomach, then reconnected the remaining anatomy to preserve function. Taylor describes her disease as aggressive, noting that she feels stable for only about three months before each scan could overturn her world. Despite the uncertainty, she remains determined: “There’ve been times where I’ve said, ‘Maybe I just shouldn’t do the treatment,’ … but then in real life what does everybody around me do? I can’t give up just because things are hard.”
Howard Robinson II of Portage shares a similarly stark narrative. At 36 in 2020, he was diagnosed with Stage 3 colorectal cancer after noticing changes in his bowel movements. He trusted his own sense that something was off, despite normal stool and blood tests. His doctor ordered a colonoscopy, which revealed the mass. Robinson endured two surgeries, chemotherapy, and radiation, and has now been cancer‑free for five years. He urges others not to ignore bodily signals: “If I had done that I wouldn’t be here.” Like Taylor, Robinson has no family history of colorectal cancer, underscoring that the disease can strike without hereditary warning signs.
The Colorectal Cancer Alliance highlights that early‑onset colorectal cancer is increasing, yet the reasons remain unclear. Michael Sapienza, the Alliance’s CEO, notes that while overall colorectal cancer survival is about 60 %, late‑stage (stage 3‑4) disease drops to a mere 13 % five‑year survival. He attributes much of this poor outcome to symptom dismissal by clinicians, which delays diagnosis until the cancer has advanced. The Alliance advises that everyone—regardless of family history or perceived risk—should begin screening colonoscopies at age 45, and anyone experiencing persistent changes in bowel habits, blood in stool, unexplained weight loss, or night sweats should seek evaluation sooner.
Taylor continues her immunotherapy regimen, holding onto hope while acknowledging the emotional toll of frequent scans. She draws strength from her sons and the knowledge that giving up would disappoint those who depend on her. Both survivors stress the importance of listening to one’s body, advocating for necessary tests, and seeking second opinions when concerns are minimized. For further guidance, the Colorectal Cancer Alliance and the American Cancer Society offer detailed resources on symptoms, screening, and treatment options.